Management including treatment The clinical goals of management are correction of acidosis and early supplementation with vitamin C (ascorbic acid) and vitamin E (alpha-tocopherol) [19]
Panizzutti B, Bortolasci C, Hasebe K, Kidnapillai S, Gray L, Walder K, et al
Damage to the endothelium can initiate BBB breakdown, contributing to the development of cSVD ( Figure 2 )
Consistency and high bioavailability are far more effective than high-dose, low-quality supplements
Treatment includes: 250 mL or 500 mL 0.9% Normal Saline Vitamin C Magnesium Arginine Methylcobalamin (B12) B-Complex Taurine Glutathione EMSELLA CHAIR- A breakthrough treatment for incontinence and
Ataxin-3, DNA damage repair, and SCA3 cerebellar degeneration: on the path to parsimony